Alex Morozov
About Alex Morozov
Alex Morozov is the VP, Head of Digital Health, Global Drug Development at Bristol Myers Squibb, with extensive experience in oncology and digital health.
Title
Alex Morozov is the Vice President, Head of Digital Health, Global Drug Development at Bristol Myers Squibb. In this role, he oversees the implementation of digital health strategies to enhance drug development processes.
Company
Alex Morozov is currently employed at Bristol Myers Squibb, a global biopharmaceutical company headquartered in Princeton, New Jersey, United States. Bristol Myers Squibb focuses on discovering, developing, and delivering innovative medicines to help patients overcome serious diseases.
Education and Expertise
Alex Morozov holds an MD-PhD in Medicine and Genetics from Albert Einstein College of Medicine, achieved after studying from 1996 to 2004. He also holds a BS in Biology from the Massachusetts Institute of Technology, which he completed between 1993 and 1995. His expertise lies in the fields of oncology, digital health, and clinical development.
Professional Background
Alex Morozov has extensive experience in the pharmaceutical and medical fields. He previously served as Vice President, Oncology Clinical Team Leader at Bristol Myers Squibb from 2019 to 2021. At Pfizer, he held roles including Clinical Group Leader, Oncology, Clinical Development and Operations from 2016 to 2019, and Senior Medical Director, Global Clinical Leader - Immunooncology from 2015 to 2016. His earlier experience includes roles at Novartis, New York Presbyterian Hospital, ImClone Systems (a subsidiary of Eli Lilly), and Memorial Sloan-Kettering Cancer Center.
Achievements
Alex Morozov has authored several peer-reviewed publications in oncology and digital health. He has led cross-functional teams to integrate digital health solutions into clinical trials, enhancing patient monitoring and data collection. He has presented at major industry conferences such as ASCO and HIMSS. At Bristol-Myers Squibb, he received the 'Innovator of the Year' award for his contributions to digital health initiatives. Additionally, he holds multiple patents related to digital health technologies and actively mentors junior researchers and clinicians.